Learn more
Log in
0 followers
Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression.
Industries
Headquarters
Stage
Employees
Links
Marie Labus
4 members
5 members
GOURMEY
16 followers
iLoF
1 follower
The Academy of Medical Sciences
Landmark Bio
Bond UK
9 followers
Discover companies